Skip to main content

John Boyce, Stephen Fodor, Jorge Velarde

Premium
John Boyce has left his post as head of business development at Helicos BioSciences to co-found Delphi Bio, a strategic biotechnology consulting firm specializing in the areas of biotechnology tools and consumables. Prior to joining Helicos, Boyce was senior director of commercial development for Parallele Biosciences. He was also senior director of business development for Genomics Collaborative. Before that, he was director for US sales at Sequenom.
 

 
Stephen Fodor plans to step down as CEO of Affymetrix on Jan. 1, the company said last week. Kevin King, Affymetrix’s president, will become CEO and a member of the board of directors. Fodor will remain a full-time executive chairman, a position in which he will “identify and advance new platform technologies and explore new market opportunities for the company,” Affymetrix said in a statement.
 

 
Illumina has promoted Jorge Velarde, Jr. to vice president of business development. Prior to joining Illumina seven years ago, he was a senior manager of business development at Gen-Probe.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.